Title:
PHARMACEUTICAL USE OF FXIA INHIBITOR COMPOUND OR SALT THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/083707
Kind Code:
A1
Abstract:
Provided is a pharmaceutical use of an FXIa inhibitor compound or a salt thereof. Specifically, provided is a use of the FXIa inhibitor compound or the salt thereof in preparation of drugs for prevention and/or treatment of arterial and venous thrombosis.
Inventors:
XIAO YING (CN)
WU JUNJUN (CN)
XING WEI (CN)
WANG RUHUAN (CN)
HUANG WEIXIN (CN)
LU YINSUO (CN)
WU JUNJUN (CN)
XING WEI (CN)
WANG RUHUAN (CN)
HUANG WEIXIN (CN)
LU YINSUO (CN)
Application Number:
PCT/CN2021/125450
Publication Date:
April 28, 2022
Filing Date:
October 22, 2021
Export Citation:
Assignee:
SHENZHEN SALUBRIS PHARM CO LTD (CN)
International Classes:
A61K31/50; A61P7/02; A61P9/00; A61P9/10; C07D237/16
Domestic Patent References:
| WO2021057818A1 | 2021-04-01 | |||
| WO2018041122A1 | 2018-03-08 | |||
| WO2017023992A1 | 2017-02-09 |
Foreign References:
| CN112675173A | 2021-04-20 | |||
| CN102026996A | 2011-04-20 | |||
| CN107793396A | 2018-03-13 | |||
| US20170291892A1 | 2017-10-12 |
Download PDF: